Hot topics: New hope for lung cancer! Lorlatinib latest price in 2023

Lorlatinib is a next-generation tyrosine kinase inhibitor specifically designed to treat ALK (tyrosine kinase) or ROS proto-oncogene in patients with non-small cell lung cancer (NSCLC) 1) Gene mutation. As a first-line treatment and a new option to combat drug resistance, lorlatinib exhibits excellent pharmacological properties and efficacy.

Lorlatinib has been launched in China and is included in medical insurance. Patients can purchase it domestically, but the price is relatively high, about 10,000 to 20,000 yuan. For specific medical insurance reimbursement prices, please consult the local hospital pharmacy. There are original lorlatinib drugs and cheaper generic drugs abroad. The cheaper ones are the original drug from Turkey, which costs more than 1,000 yuan, and the original drug from Hong Kong, China, which costs about 30,000 yuan. Generic drugs are mainly generic drugs from Laos and Bangladesh. The price is about several thousand yuan, and the ingredients of the original drugs and generic drugs are basically the same.

One of the greatest features of lorlatinib is its broad inhibitory activity, able to target a variety ofALK mutations, including those that confer resistance to otherALK inhibitors. This makes lorlatinib an important tool in the treatment of NSCLC, especially in patients who develop ALK gene mutations during treatment.

In addition, lorlatinib is also active againstROS1 gene mutations, further broadening its scope of application. This makes lorlatinib a comprehensive treatment option for ALK and ROS1-positive NSCLC, providing new treatment hope for more patients.

Larlatinib has the ability to cross the blood-brain barrier, so it has shown significant effects in the treatment of NSCLC with brain metastases. This is an important therapeutic breakthrough for patients for whom brain metastases are a major challenge in their disease.

However, like all medications, lorlatinib may cause some side effects, including but not limited to visual disturbances, gastrointestinal discomfort, and liver function abnormalities. Therefore, before using lorlatinib, patients should undergo a comprehensive health assessment and fully communicate with their doctor to ensure the best treatment effect and the patient's overall health.